Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7929237rdf:typepubmed:Citationlld:pubmed
pubmed-article:7929237lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:7929237lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:7929237lifeskim:mentionsumls-concept:C0001492lld:lifeskim
pubmed-article:7929237lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:7929237lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:7929237lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:7929237pubmed:issue41lld:pubmed
pubmed-article:7929237pubmed:dateCreated1994-11-17lld:pubmed
pubmed-article:7929237pubmed:abstractTextThe type I adenylyl cyclase is directly stimulated by Ca2+ and calmodulin in vivo (Choi, E. J., Wong, S. T., Hinds, T. R. and Storm, D. R. (1992) J. Biol. Chem. 267, 12440-12442; Wu, Z., Wong, S. T., and Storm, D. R. (1993) J. Biol. Chem. 268, 23766-23768). In this study, we examined the sensitivity of the type I adenylyl cyclase expressed in HEK-293 cells to beta-adrenergic agonists or glucagon when intracellular Ca2+ was elevated by Ca2+ ionophore or carbachol. Although previous studies have shown that this enzyme can be directly stimulated by activated Gs in vitro, we demonstrate that it is not stimulated by Gs-coupled receptors in vivo. However, the enzyme was stimulated by Gs-coupled receptors in vivo when it was activated by intracellular Ca2+. For example, the Ca2+ ionophore A23187 stimulated the enzyme 3 +/- 0.5-fold (n = 9) and isoproterenol alone did not stimulate the enzyme, but the combination of the two stimulated type I adenylyl cyclase 13 +/- 2-fold (n = 9) in vivo. Similarly, 500 nM glucagon alone did not stimulate the enzyme but the combination of A23187 and glucagon activated the enzyme 90 +/- 8-fold (n = 4). Synergistic stimulation of type I adenylyl cyclase activity was also obtained with combinations of carbachol and isoproterenol or glucagon. This phenomenon was not observed with a mutant enzyme that is insensitive to Ca2+ and calmodulin, suggesting that conformational changes caused by binding of calmodulin to the type I adenylyl cyclase enhance binding or coupling to activated Gs. These data illustrate that this adenylyl cyclase can couple Ca2+ and neurotransmitter signals to generate optimal cAMP levels, a property of the enzyme that may be important for its role in learning and memory in mammals.lld:pubmed
pubmed-article:7929237pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:languageenglld:pubmed
pubmed-article:7929237pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:citationSubsetIMlld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7929237pubmed:statusMEDLINElld:pubmed
pubmed-article:7929237pubmed:monthOctlld:pubmed
pubmed-article:7929237pubmed:issn0021-9258lld:pubmed
pubmed-article:7929237pubmed:authorpubmed-author:StoryD FDFlld:pubmed
pubmed-article:7929237pubmed:authorpubmed-author:WuZZlld:pubmed
pubmed-article:7929237pubmed:authorpubmed-author:PrichardLLlld:pubmed
pubmed-article:7929237pubmed:authorpubmed-author:KindsvogelWWlld:pubmed
pubmed-article:7929237pubmed:authorpubmed-author:WaymanG AGAlld:pubmed
pubmed-article:7929237pubmed:authorpubmed-author:ImpeySSlld:pubmed
pubmed-article:7929237pubmed:issnTypePrintlld:pubmed
pubmed-article:7929237pubmed:day14lld:pubmed
pubmed-article:7929237pubmed:volume269lld:pubmed
pubmed-article:7929237pubmed:ownerNLMlld:pubmed
pubmed-article:7929237pubmed:authorsCompleteYlld:pubmed
pubmed-article:7929237pubmed:pagination25400-5lld:pubmed
pubmed-article:7929237pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:meshHeadingpubmed-meshheading:7929237-...lld:pubmed
pubmed-article:7929237pubmed:year1994lld:pubmed
pubmed-article:7929237pubmed:articleTitleSynergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo.lld:pubmed
pubmed-article:7929237pubmed:affiliationDepartment of Pharmacology, University of Washington, Washington 98195.lld:pubmed
pubmed-article:7929237pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7929237pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:2641entrezgene:pubmedpubmed-article:7929237lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7929237lld:pubmed